Clinical observation of heat-sensitive moxibustion treatment for coronavirus disease 2019.
10.13703/j.0255-2930.20200312-k0003
- Author:
Xian-Bao HUANG
1
;
Ding-Yi XIE
1
;
Qi QIU
1
;
Yang SHEN
1
;
Lin JIAO
1
;
Qiao-Lin LI
1
;
Ri-Xin CHEN
1
Author Information
1. Affiliated Hospital of Jiangxi University of TCM, Nanchang 330006, China.
- Publication Type:Journal Article
- Keywords:
chest distress;
coronavirus disease 2019 (COVID-19);
heat-sensitive moxibustion;
impaired appetite;
moxibustion;
negative emotion
- MeSH:
Acupuncture Points;
Betacoronavirus;
Coronavirus Infections;
therapy;
Hot Temperature;
Humans;
Moxibustion;
Pandemics;
Pneumonia, Viral;
therapy
- From:
Chinese Acupuncture & Moxibustion
2020;40(6):576-580
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe clinical effect of heat-sensitive moxibustion on coronavirus disease 2019 (COVID-19) and to discusses the effective moxibustion treatment program.
METHODS:A total of 42 patients with COVID-19 (general type) were treated with heat-sensitive moxibustion at the acupoint area of Shenque (CV 8) and Tianshu (ST 25). The treatment was conducted under the standards of heat-sensitive moxibustion manipulation, which were "locating acupoint by feeling, moxibustion by differentiate sensation, dosage varies individually, ending after sufficient dosage". The incidence of after first heat-sensitive moxibustion, the reduction of negative emotions, the improvement of chest distress and impaired appetite, and the active acceptance rate of moxibustion before and after treatment were observed.
RESULTS:① The rate of heat-sensitive moxibustion for 20 min、40 min、1 h were respectively 52.4% (22/42), 90.5% (38/42), 100.0% (42/42). ② The incidences of feeling relaxed and comfortable immediately after the first, second, and third heat-sensitive moxibustion were 61.9% (26/42), 73.8% (31/42), and 92.9% (39/42), which were higher than 42.9% (18/42) before heat-sensitive moxibustion treatment (<0.05). ③ The incidences of chest distress after the first, second, and third heat-sensitive moxibustion were 23.8% (10/42), 16.7% (7/42), and 9.5% (4/42), which were lower than 50.0% (21/42) before heat-sensitive moxibustion treatment (<0.05); the incidences of impaired appetite after the first, second, and third heat-sensitive moxibustion were 26.2% (11/42), 19.0% (8/42), 9.5% (4/42), which were lower than 57.1% (24/42) before heat-sensitive moxibustion treatment (<0.05). ④ After the first treatment, the active acceptance rate of patients for heat-sensitive moxibustion was 100.0% (42/42), which was higher than 11.9% (5/42) before heat-sensitive moxibustion (<0.05).
CONCLUSION:The heat-sensitive moxibustion can effectively reduce the negative emotions and improve the symptoms of chest distress and impaired appetite with COVID-19. It is generally accepted by patients, and worthy of popularization and application in clinical treatment.
